Evidence map›Paper›PMID 35378204›Full record

ArticleAlcohol (Fayetteville, N.Y.)2022

Purkinje cell-specific deletion of CREB worsens alcohol-induced cerebellar neuronal losses and motor deficits.

Dylan Todd, Michael Clapp, Parker Dains, Bahri Karacay, Daniel J Bonthius

Open access · greenAbstract read
In one paragraph

Article in Alcohol (Fayetteville, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dylan ToddNeuroscience Program, University of Iowa Carver College of Medicine, Iowa City, IA, United States.
Michael ClappDepartment of Pediatrics, University of Iowa, Carver College of Medicine, Iowa City, IA, United States.
Parker DainsDepartment of Pediatrics, University of Iowa, Carver College of Medicine, Iowa City, IA, United States.
Bahri KaracayDepartment of Pediatrics, University of Iowa, Carver College of Medicine, Iowa City, IA, United States.
Daniel J BonthiusNeuroscience Program, University of Iowa Carver College of Medicine, Iowa City, IA, United States; Department of Pediatrics, University of Iowa, Carver College of Medicine, Iowa City, IA, United States; Atrium Health/Levine Children's Hospital, Charlotte, NC, United States. Electronic address: daniel.bonthius@atriumhealth.org.
University of Iowa · US

Funding

NO-mediated neuroprotection against alcohol: mechanism and potential therapyR01AA021465 · NIAAA · UNIVERSITY OF IOWA · PI BONTHIUS, DANIEL J. · 2013 to 2017
$1.7M
Prevention of Alcohol Neurotoxicity by PDE4 InhibitorR21AA018711 · NIAAA · UNIVERSITY OF IOWA · PI BONTHIUS, DANIEL J., KARACAY, BAHRI · 2010 to 2011
$404k
NIAAA NIH HHS R01 AA021465NIAAA NIH HHS R21 AA018711
6 · The paper itself

Abstract

introductionExposure to alcohol during pregnancy can kill developing fetal neurons and lead to fetal alcohol spectrum disorder (FASD) in the offspring. However, not all fetuses are equally vulnerable to alcohol toxicity. These differences in vulnerability among individuals are likely due, at least in part, to genetic differences. Some genes encode neuroprotective molecules that act through signaling pathways to protect neurons against alcohol's toxic effects. One signaling pathway that can protect cultured neurons against alcohol-induced cell death in vitro is the cAMP pathway. A goal of this study was to determine whether the cAMP pathway can exert a similar neuroprotective effect against alcohol in vivo. A key molecule within the cAMP pathway is cAMP response element binding protein (CREB). In this study, CREB was specifically disrupted in cerebellar Purkinje cells to study its role in protection of cerebellar neurons against alcohol toxicity.

methodsMice with Purkinje cell-specific knockout of CREB were generated with the Cre-lox system. A 2 × 2 design was used in which Cre-negative and Cre-positive mice received either 0.0 or 2.2 mg/g ethanol by intraperitoneal (i.p.) injection daily over postnatal day (PD) 4-9. Stereological cell counts of cerebellar Purkinje cells and granule cells were performed on PD 10. Motor function was assessed on PD 40 using the rotarod.

resultsPurkinje cell-specific disruption of CREB alone (in the absence of alcohol) induced only a small reduction in Purkinje cell number. However, the loss of CREB function from Purkinje cells greatly increased the vulnerability of Purkinje cells to alcohol-induced cell death. While alcohol killed 20% of Purkinje cells in the Cre-negative (CREB-expressing) mice, alcohol killed 57% of Purkinje cells in the Cre-positive (CREB-nonexpressing) mice. This large loss of Purkinje cells did not lead to similar alcohol-induced losses of granule cells. In the absence of alcohol, lack of CREB function in Purkinje cells had no effect on rotarod performance. However, in the presence of alcohol, disruption of CREB in Purkinje cells substantially worsened rotarod performance. DISCUSSION: Disruption of a single gene (CREB) in a single neuronal population (Purkinje cells) greatly increases the vulnerability of that cell population to alcohol-induced cell death and worsens alcohol-induced brain dysfunction. The results suggest that the cAMP pathway can protect cells in vivo against alcohol toxicity and underline the importance of genetics in determining the neuropathology and behavioral deficits of FASD.

Indexed as

Fetal Alcohol Spectrum DisordersPurkinje CellsAnimalsCerebellumCyclic AMP Response Element-Binding ProteinEthanolFemaleHumansMiceMice, KnockoutNitric Oxide Synthase Type IPregnancyCyclic AMP Response Element-Binding ProteinEthanolNitric Oxide Synthase Type IcAMPFetal alcohol syndromeGeneticsRotarod

Identifiers

PMID35378204
PMCPMC9783827
OpenAlexW4220765292

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.